Back to UBS Group AG UBS Group AG

IMUXIMUX
Showing 8 of 27 quarters

Position history for UBS Group AGUBS Group AG's holdings in IMMUNIC INC

UBS Group AG holds 175,756 shares of IMUX (IMMUNIC INC), worth $2.7M as of 2026-Q2. The position was decreased (-66.4% shares). IMUX represents 0.0% of UBS Group AG's portfolio.

Current Value

$2.7M

Current Shares

175,756

Total Value Change

+$2.7M

Total Shares Change

+173,317

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
175,756
-66.4%
$2.7M0.0%$15.37
0
2026-Q1
Decreased
522,797
-2.7%
$580,3050.0%$11.10
0
2025-Q4
Increased
537,118
+1288.4%
$286,8220.0%$5.34
26
2025-Q3
Decreased
38,687
-89.7%
$34,1220.0%$8.82
0
2025-Q2
Increased
376,104
+152.3%
$262,5210.0%$6.98
26
2025-Q1
Increased
149,050
+448.0%
$162,4650.0%$10.90
25
2024-Q4
Increased
27,197
+1015.1%
$27,1970.0%$10.00
21
2024-Q3
Increased
2,439
+80.1%
$4,0240.0%$16.50
15

Other major holders of IMUX: BNP PARIBAS FINANCIAL MARKETS, RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used